What are the causes and treatments of encephalopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes and Treatment of Encephalopathy

Causes of Encephalopathy

Encephalopathy has multiple etiologies that must be systematically excluded before attributing altered mental status to a single cause, with hepatic encephalopathy being the most common in cirrhotic patients but requiring differentiation from infectious, metabolic, structural, and toxic causes. 1

Hepatic Encephalopathy - Precipitating Factors

The most critical aspect of managing hepatic encephalopathy is identifying precipitating factors, which are present in 80-90% of cases and resolve symptoms in approximately 90% when corrected: 1, 2, 3

  • Infections (spontaneous bacterial peritonitis, urinary tract infections, pneumonia) 1, 2
  • Gastrointestinal bleeding (variceal or non-variceal) 1, 2, 3
  • Constipation 1, 2, 3
  • Dehydration and electrolyte disturbances (hyponatremia, hypokalemia) 1, 2, 3
  • Sedative medications (benzodiazepines, opioids) 1, 2
  • Proton pump inhibitor use 1
  • Hepatocellular carcinoma 4

Other Causes to Exclude

Brain imaging (CT or MRI) should be performed in first-time presentations, as intracranial hemorrhage risk is 5-fold increased in cirrhotic patients: 1, 3

  • Intracranial hemorrhage or stroke 1, 3
  • Infectious encephalitis (HSV, VZV, CMV in immunocompromised) 1
  • Metabolic encephalopathy (uremia, hypoglycemia, hypoxia) 1
  • Toxic encephalopathy (alcohol, drugs) 1
  • In returning travelers: malaria, tuberculous meningitis, dengue, Japanese encephalitis 1

Treatment of Hepatic Encephalopathy

Four-Pronged Management Approach

Treatment follows a systematic four-step approach: airway protection for altered consciousness, exclusion of alternative causes, identification and correction of precipitating factors, and empirical hepatic encephalopathy treatment. 1, 2

Step 1: Initial Stabilization

  • Grade III-IV encephalopathy requires ICU admission with airway protection and intensive monitoring 1, 2
  • Grade I-II encephalopathy can be managed on a medicine ward with frequent mental status checks 2
  • Avoid sedatives as they worsen encephalopathy and have delayed clearance in liver failure 2

Step 2: Identify and Correct Precipitating Factors

This is the cornerstone of management and resolves nearly 90% of cases: 1, 2, 3

  • Treat infections with appropriate antibiotics 1, 2
  • Control gastrointestinal bleeding 1, 2
  • Correct dehydration and electrolyte abnormalities 1, 2, 3
  • Discontinue sedatives and unnecessary medications 1, 2
  • Relieve constipation 1, 2, 3

Step 3: Pharmacologic Treatment

First-Line: Lactulose

Lactulose is the first-line treatment for overt hepatic encephalopathy, with dosing titrated to achieve 2-3 soft stools daily. 1, 2, 3, 5

Dosing regimen: 5

  • Acute treatment: 30-45 mL (20-30 grams) orally every 1-2 hours until bowel movement occurs, then reduce to maintenance dosing 1, 5
  • Maintenance: 30-45 mL three to four times daily, adjusted to produce 2-3 soft stools per day 5
  • Rectal administration: 300 mL lactulose mixed with 700 mL water/saline as retention enema for 30-60 minutes every 4-6 hours when oral route unavailable 5

Mechanism: Acidification of the gastrointestinal tract inhibits ammonia production by coliform bacteria 6

Common pitfall: Overuse of lactulose can cause aspiration, dehydration, hypernatremia, and severe perianal irritation—do not use excessive doses beyond what achieves 2-3 stools daily 1, 2

Second-Line: Rifaximin

Rifaximin is recommended as secondary prophylaxis after recurrent episodes of overt hepatic encephalopathy, typically added to lactulose: 1, 2, 3

  • Dosing: 550 mg twice daily 6
  • Mechanism: Decreases intestinal ammonia production by altering gastrointestinal flora with minimal systemic absorption 6
  • Rifaximin is equal or superior to lactulose in clinical studies with fewer side effects 6, 7

Step 4: Nutritional Management

Address malnutrition present in approximately 75% of patients: 2, 3

  • Provide moderate hyperalimentation with small, frequent meals throughout the day, including a late-night snack 2, 3
  • Protein intake: Start at 0.5 g/kg/day and progressively increase to 1-1.5 g/kg/day 8
  • Prefer dairy products and vegetable-based diets over meat-based protein 8
  • Multivitamin supplementation is generally recommended 2

Prophylaxis Strategies

Secondary prophylaxis with lactulose is mandatory after any episode of overt hepatic encephalopathy to prevent recurrence. 1, 2, 3

  • After first episode: Continue lactulose at maintenance dosing (2-3 soft stools daily) 1, 2, 3
  • After recurrent episodes: Add rifaximin 550 mg twice daily to lactulose 1, 2, 3
  • Prophylaxis may only be discontinued when precipitating factors are well-controlled, infections treated, variceal bleeding resolved, or liver function significantly improved 3

Diagnostic Considerations

Blood Ammonia Levels

Blood ammonia levels do not add diagnostic, staging, or prognostic value for hepatic encephalopathy; however, a normal ammonia level should prompt reconsideration of the diagnosis. 1, 2, 3

Screening for Covert (Minimal) Hepatic Encephalopathy

  • Use the animal naming test to detect covert hepatic encephalopathy 1, 2
  • A therapeutic trial with lactulose or rifaximin may strengthen the diagnosis 1
  • Consider testing in patients with impaired quality of life, work performance, or driving ability 1

Special Considerations

Liver Transplantation

Recurrent intractable overt hepatic encephalopathy with liver failure is an indication for liver transplantation evaluation. 1, 2, 3

  • A single episode of hepatic encephalopathy should prompt evaluation for transplantation 2
  • Neurological work-up should be performed before transplantation to exclude other causes of neurological disorders 1

TIPS Placement

A single episode of hepatic encephalopathy is not a contraindication to TIPS placement 1


Common Pitfalls to Avoid

  • Failing to identify and correct precipitating factors, which resolve 90% of cases 1, 2, 3
  • Not titrating lactulose adequately to achieve 2-3 stools per day 1, 2
  • Confusing hepatic encephalopathy with other causes of altered mental status without proper exclusion 1, 2
  • Relying exclusively on ammonia levels for diagnosis 1, 2, 3
  • Not implementing secondary prophylaxis after the first episode 1, 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hepatic Encephalopathy Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hepatic Encephalopathy Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Current trends in the treatment of hepatic encephalopathy.

Therapeutics and clinical risk management, 2009

Research

Hepatic Encephalopathy.

The American journal of gastroenterology, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.